BlackRock

BlackRock, established in 1988, is a global investment management corporation headquartered in New York City. It offers a wide range of services, including investment management, financial technology, and advisory services, catering to diverse clients such as institutions, intermediaries, and individual investors. BlackRock's investment focus spans multiple asset classes, strategies, sectors, and regions. Its private equity arm, BlackRock Private Equity Partners, founded in 1999, specializes in direct investments and fund of fund investments across various stages and sectors, with a global investment scope.

Joseph Acevedo

Managing Director

Joseph Auriemma

Managing Director, Private Equity

Cailey Barker

Portfolio Manager and Director, Natural Resources and Thematic

James Berner

Partner, Global Infrastructure Partners

Paul Braude

Managing Director, Chief Investment Officer and Head, Direct Private Opportunities

Joseph Chalom

Managing Director and Head of Strategic Ecosystem Partnerships

Al DeFurianni

Vice President

Antonio DeSpirito

Managing Director and Global Co-Chief Investment Officer, US Fundamental Equities

Audrey Delorenzo

Vice President

Michael Dennis

Managing Director and Head of Alternatives Strategy and Capital Markets

Sean Dunne

Managing Director

Tim Fenwick

Director

David Giordano

Managing Director and Global Head of Climate Infrastructure

Raja Hussain

Director

Robert S. Kapito

President and Director

Tony Kim

Managing Director and Head of the Global Technology Team

Michael Leitner

Managing Director, Co-head of US Direct Lending and Special Situations

Courtney Lynfield

Vice President, Long Term Private Capital Product Strategy

Keith Mangan

Managing Director, Renewable Power

Nathalie von Niederhausern

Managing Director and Head of EMEA for Private Equity Partners

Persefoni Noulika

Director

Charlie Reid

Managing Director

Jean-Christophe Rey

Managing Director and Head of Private Credit, Alternative Specialists (EMEA)

Spencer Rhodes

Managing Director, Private Markets at BlackRock

Ladell Robbins

Managing Director, Alternative Investors

Jeffrey Rosenberg

Managing Director and Senior Portfolio Manager, Systematic Fixed Income

Neeraj Seth

Chief Investment Officer and Head of Asia pacific Fundamental Fixed Income

Scott Snell

Co-head of the US CLO business and Director

Aarthi Sowrirajan

Managing Director and Co-Head of Portfolio Management for BlackRock Impact Opportunities

Paul Taylor

Venture Partner

Martin Torres

Managing Director and Head of the Americas for the Renewable Power Group

Marten Vading

Managing Director

Guillaume Vandewalle

Director Infrastructure Debt EMEA

Zachary Viders

Managing Director and Portfolio Manager, Global Credit Opportunities

Celia Yan

Managing Director and Head of APAC Private Credit

Yan Yang

Managing Director

Past deals in Series C

Marshmallow

Series C in 2025
Marshmallow Financial Services Limited, known as Marshmallow, is a London-based insurtech company that specializes in motor vehicle insurance. Founded in 2017, it focuses on providing car insurance products for residents relocating to the United Kingdom. Marshmallow aims to simplify the insurance process through technology, offering features such as instant policy management, personal support, and no administrative fees. The company controls the entire value chain, from sign-up and pricing to claims, which enhances the customer experience. While it began with car insurance, Marshmallow plans to expand its offerings to include various insurance products across multiple regions.

Celestial AI

Series C in 2025
Celestial AI is a prominent artificial intelligence company that provides an advanced platform for users to efficiently create images, text, and presentations. Utilizing computer vision algorithms and natural language processing, the platform produces high-quality visual and textual content. Its intuitive design and innovative features simplify the creation process, while intelligent data integration and a commitment to security ensure reliable results.

Numab

Series C in 2025
Numab is a biotechnology company focused on developing antibody-based therapies for severe diseases like chronic inflammation and cancer. Its proprietary platform streamlines the discovery process by reducing randomness, predictably generating ready-to-develop multispecific biotherapeutics tailored to engage multiple targets simultaneously. This enables healthcare industries to access Numab's platform for innovative treatments in these areas.

Upvest

Series C in 2024
Upvest GmbH, founded in 2017 and based in Vaduz, Liechtenstein, specializes in providing a blockchain application programming interface (API) that allows businesses to create tailored investment experiences for their customers. The company’s single investment API and digital infrastructure enable financial institutions to seamlessly integrate and offer customized investment products, including the ability to configure savings plans and facilitate micro-investing through roundups. Upvest supports a variety of decentralized applications, tokenized platforms, exchanges, and wallet services, connecting them with major open-source protocols such as Bitcoin and Ethereum. The modular design of their offerings ensures that businesses can easily adapt and scale their investment solutions while receiving comprehensive support for licenses and vendor management, as well as back-office operations.

Bright Machines

Series C in 2024
Bright Machines, Inc. is a manufacturing company founded in 2018 and based in San Francisco, California, with additional offices in Tel Aviv, China, and Mexico. The company specializes in creating robotic arms and cells for micro factories, focusing on the assembly and inspection of electronic products. It aims to reduce manual labor in manufacturing by integrating advanced robotics with a software-defined manufacturing platform. This platform leverages artificial intelligence, machine learning, and production data to enhance automation processes, resulting in robots that are adaptable and equipped with sensor technology and computer vision. Bright Machines enables its clients to innovate rapidly and achieve better production yields at lower costs, meeting the evolving demands of the manufacturing sector.

Securitize

Venture Round in 2024
Securitize, Inc. operates a compliance platform designed for the issuance and management of digital securities. Founded in 2017 and based in Redwood City, California, the company facilitates various services for issuers, including digital security issuance, document handling, investor communications, and accreditation. For investors, Securitize offers features such as wallet management, an investor dashboard, and token distribution. The platform also includes support services like fiat and crypto escrow, along with custodial services. Securitize is distinguished as the only SEC Registered Transfer Agent integrated with multiple regulated U.S.-based marketplaces, enabling eligible investors to own, manage, and trade digital securities across sectors like equity, funds, fixed income, and real estate. The company's approach enhances transparency, liquidity, and efficiency in the tokenization process, while also providing KYC/AML and capital management services.

RapidSOS

Series C in 2024
RapidSOS, Inc. is an emergency response data platform that connects life-saving information from over 350 million devices directly to 9-1-1 and first responders during emergencies. Founded in 2012 and based in New York, the company offers a range of solutions including Clearinghouse, which enables users to send emergency requests from RapidSOS-enabled devices, and an Emergency API suite that delivers user data to emergency services. Additionally, the RapidSOS Portal provides public safety agencies with secure access to essential Next Generation 911 (NG911) data. The platform supports more than 4,800 Emergency Communications Centers and plays a vital role in protecting over 90% of the U.S. population, responding to approximately 250 million emergencies annually. By collaborating with certified partners, RapidSOS enhances response capabilities by transmitting critical data such as precise location and real-time health information, ultimately aiming to improve emergency response efficiency and save lives.

Qover

Series C in 2023
Qover is an insurtech company that specializes in providing a modular embedded insurance orchestration platform, which allows businesses and insurance providers to deliver seamless, technology-driven insurance experiences. The platform features a digital infrastructure that facilitates managing insurance services, including obtaining quotes and handling claims and contracts through an application programming interface (API) adaptable to various products, countries, and insurers. This approach has enabled Qover to serve over 4 million users across 32 European countries, partnering with notable companies such as Revolut, Monzo, Deliveroo, and NIO, among others.

OnKure Therapeutics

Series C in 2023
OnKure Therapeutics is a clinical-stage biotechnology company dedicated to the discovery and development of innovative cancer therapies. The company specializes in creating less toxic kinase inhibitor drugs and epigenetic therapies, including selective inhibitors of histone deacetylases. Its lead candidate, OKI-179, has demonstrated significant efficacy in preclinical models of hematological and solid tumor cancers, effectively reducing tumor growth both alone and in combination with other targeted therapies. Additionally, OnKure is advancing its HDAC3 selective inhibitor, OKI-422, into preclinical toxicology studies. The company's drug candidates are designed to directly target malignant cells, enhance the effects of small molecule therapies, and optimize the tumor microenvironment for improved checkpoint inhibition, addressing unmet medical needs in cancer treatment.

Razor Group

Series C in 2023
Razor Group is a global consumer holding company that partners with established e-commerce merchants to acquire and scale their brands. The company invests significant capital and leverages its extensive e-commerce expertise to propel these acquired merchants to the next stage of development. Razor focuses on specific product categories, enhancing long-term brand value, and ensuring first-class customer satisfaction through advanced data analytics and custom-built technology.

Chain Reaction

Series C in 2023
Chain Reaction is focused on advancing blockchain and privacy technologies designed to enhance computing performance. Their blockchain product line features EL3CTRUM, which includes the most efficient hashing ASIC available, optimized for high performance and low power consumption. This serves as the core of their hashboards and systems, providing optimal payback times for users. Additionally, their 3PU™ privacy solution significantly accelerates the real-time operations of Privacy Enhancing Technologies on encrypted data, transforming cloud environments into trusted platforms. This enables various sectors, including finance, healthcare, defense, and energy, to adopt cloud solutions at scale. Chain Reaction's purpose-built, custom-designed technologies aim to facilitate secure, scalable, and environmentally friendly computing, ultimately contributing to the protection of individuals, privacy, and the planet.

Razor Group

Private Equity Round in 2022
Razor Group is a global consumer holding company that partners with established e-commerce merchants to acquire and scale their brands. The company invests significant capital and leverages its extensive e-commerce expertise to propel these acquired merchants to the next stage of development. Razor focuses on specific product categories, enhancing long-term brand value, and ensuring first-class customer satisfaction through advanced data analytics and custom-built technology.

Wagestream

Series C in 2022
Wagestream Ltd., founded in 2018 and headquartered in London, United Kingdom, develops a financial services application designed to enhance employee benefits and financial well-being. The platform allows employees to access their earned wages instantly, providing them with greater control over their pay schedules. This innovation aims to alleviate financial stress related to unexpected expenses by eliminating the need for advances, loans, and the burdens of high-interest credit or payday loans. Additionally, Wagestream offers various financial tools that help businesses support their employees in managing expenses, setting savings goals, and developing financial plans. By addressing these financial challenges, Wagestream seeks to reduce the poverty premium and prevent employees from falling into cycles of debt.

Dream Games

Series C in 2022
Dream Games is a mobile gaming company based in Istanbul, Turkey, founded in 2019. The company focuses on developing high-quality, scalable interactive mobile games that aim to provide immersive and competitive experiences for users. By blending technology and creativity, Dream Games specializes in casual and multiplayer video games, ensuring that its titles are engaging and enjoyable for players over the long term.

Ursa Major

Series C in 2021
Ursa Major Technologies, Inc., established in 2015 and based in Berthoud, Colorado, specializes in manufacturing propulsion solutions tailored for the microsatellite and nanosatellite launch market. The company's product portfolio includes the Ursa Major Hadley and Ripley engines, which are predominantly (over 80%) additively manufactured using innovative, in-house developed materials and processes. These engines, running on liquid oxygen and kerosene, are designed to provide superior performance, reliability, and cost-effectiveness for aerospace clients.

Teya

Series C in 2021
Teya is a comprehensive solution tailored for small and growing businesses, offering a suite of services that facilitate efficient management and growth. The company specializes in payment processing, providing fast and secure transaction capabilities, along with cloud-native business management software. Teya's offerings include issuer payment processing and cash advance services, which assist merchants in enhancing their operations. With a commitment to supporting over 300,000 business owners, Teya enables them to effectively manage their businesses and fosters a positive experience in their entrepreneurial journey.

Noodle

Series C in 2021
Noodle is a U.S.-based organization focused on enhancing the educational experience through innovative online and hybrid programs while also improving traditional classroom models. Founded in 2010 by John Katzman, the company connects students with universities, programs, and resources by providing unbiased data and real-world insights. Noodle collaborates with higher education institutions to develop and implement certificate and degree programs, offering services in marketing, student recruitment, curriculum design, and engagement, as well as support and placement for graduates. By fostering a network of universities, education leaders, and students, Noodle aims to enhance student-faculty engagement and lower educational costs, making higher education more accessible and effective.

Noodle

Series C in 2021
Noodle is a U.S.-based organization focused on enhancing the educational experience through innovative online and hybrid programs while also improving traditional classroom models. Founded in 2010 by John Katzman, the company connects students with universities, programs, and resources by providing unbiased data and real-world insights. Noodle collaborates with higher education institutions to develop and implement certificate and degree programs, offering services in marketing, student recruitment, curriculum design, and engagement, as well as support and placement for graduates. By fostering a network of universities, education leaders, and students, Noodle aims to enhance student-faculty engagement and lower educational costs, making higher education more accessible and effective.

Solugen

Series C in 2021
Solugen, Inc. is a specialty chemicals company based in Houston, Texas, that focuses on producing industrial chemicals through industrial biotechnology and green chemistry. Founded in 2016, Solugen develops a range of environmentally friendly products, including BioPeroxide, a carbon-negative hydrogen peroxide, and BioChelate, a biodegradable chelant. The company also offers ScavSol, a multivalent metal sequestrant for energy applications; ScaleSol, an alternative to phosphonates for scale control; and CorrSol, a corrosion and fouling control product. By utilizing fermentation and enzymatic technology to convert plant sugars into chemicals, Solugen aims to replace petroleum-based products with plant-derived alternatives. Its innovative solutions are designed to benefit various industries, including agriculture, cleaning, energy, and water, while also addressing critical issues such as clean water, sustainable materials, and healthier personal care products.

Snorkel AI

Series C in 2021
Snorkel AI, Inc. is a company that develops a comprehensive machine-learning platform designed to facilitate the creation, management, and monitoring of AI applications. Its primary offering, Snorkel Flow, allows users to programmatically label and augment training data, manage and integrate various datasets, and deploy machine learning models, while also providing tools for data analysis and monitoring. The platform is particularly effective in extracting structured information from complex documents and forms, as well as ranking content based on relevance. Founded in 2016 and based in Palo Alto, California, Snorkel AI serves a diverse range of industries, including finance, government, telecommunications, insurance, healthcare, and e-commerce. The technology was developed at Stanford AI Lab and employs innovative methods such as weak supervision to enhance data preparation, thereby streamlining the AI development process for enterprises.

Exo

Series C in 2021
Exo is a medical device startup focused on revolutionizing ultrasound technology for imaging and therapeutic applications. The company has developed a handheld ultrasound platform that integrates advanced nano-materials, innovative sensor technologies, and sophisticated signal processing with the cost advantages of semiconductor manufacturing. This approach allows Exo to provide high-quality, affordable, and user-friendly medical imaging solutions. By enabling healthcare professionals to make critical, real-time decisions, Exo aims to enhance patient outcomes significantly. The company's commitment to accessibility and ease of use in medical imaging represents a significant advancement in the field, making effective diagnostic tools available at an unprecedented price point.

Elvie

Series C in 2021
Elvie is a health and lifestyle brand developing smarter technology for women. They are committed to building extraordinary products that improve the health and lives of women everywhere and at all stages of life. Their first product, Elvie Trainer, is an award-winning app-connected Kegel trainer that helps women strengthen the pelvic floor via fun, five-minute workouts. Launched in October 2015 to great acclaim, they took the wellness industry by storm! Our street cred includes more than 12 awards for innovation and design, including the prestigious CES Innovation Award, the IDA Design Award, and the Red Dot Award. As a business, Elvie has been recognized as one of Wired’s ‘hottest start-ups" and named one of the 15 start-ups "to watch" by The Sunday Times, and both products have been featured in the Oscar nominee gift bags. They recently launched a second innovation: Elvie Pump, the world’s first silent wearable breast pump, which is making it possible for new mothers to pump anytime, anywhere. Elvie Pump received international praise following its unveiling on the catwalk at London Fashion Week and at the Consumer Electronics Show (CES) in Las Vegas. In April 2019, Elvie announced a $42 million Series B led by IPGL and supported by Octopus Ventures and Impact Ventures. This represented the largest ever fundraise in femtech. This new round of financing will accelerate Elvie’s research and development efforts as well as help grow brand awareness and distribution for Elvie Pump and Elvie Trainer across the Americas, Europe, and Asia. Headquartered in London, UK, with offices also in New York City, the company has received numerous awards and raised more than $52 million in investment.

10X Banking

Series C in 2021
10X Banking, founded by former Barclays CEO Antony Jenkins, is focused on transforming financial services through its innovative core digital banking platform. This platform offers a comprehensive suite of enterprise-grade capabilities, including banking process automation, compliance reporting, security, and analytics, all built on advanced technology. 10X Banking provides a secure, cloud-based operating system designed for banks, featuring modular construction and open APIs. This technology facilitates a single point of entry for financial technology providers, allowing them to connect seamlessly with banks. By adhering to open banking principles, 10X Banking aims to help financial institutions navigate changing customer trends, market conditions, and regulatory requirements, ultimately enhancing cost-efficiency and improving customer interface connectivity within their systems.

Numab

Series C in 2021
Numab is a biotechnology company focused on developing antibody-based therapies for severe diseases like chronic inflammation and cancer. Its proprietary platform streamlines the discovery process by reducing randomness, predictably generating ready-to-develop multispecific biotherapeutics tailored to engage multiple targets simultaneously. This enables healthcare industries to access Numab's platform for innovative treatments in these areas.

Mythic

Series C in 2021
Mythic Inc. is a technology company that designs and develops silicon chips and artificial intelligence processing units (IPUs) for a wide range of applications, from consumer electronics and wearables to autonomous vehicles and robotic drones. Founded in 2012 and headquartered in Redwood City, California, with an additional office in Austin, Texas, Mythic specializes in analog matrix processors that utilize unique compute-in-memory technology. Their products, including the M1076 Analog Matrix Processor and various PCIe and M.2 cards, integrate AI capabilities directly into compact chips, enabling desktop-level processing power in smaller devices. The company emphasizes its expertise in neural networks, processor architecture, and software design to deliver efficient AI solutions while maintaining performance, power efficiency, and accuracy in real-world environments.

Omega Therapeutics

Series C in 2021
Omega Therapeutics is a development-stage biotechnology company based in Cambridge, Massachusetts, focused on developing genomic medicines aimed at curing diseases. The company utilizes its proprietary epigenomic programming platform to create a new class of programmable epigenetic medicines, referred to as Omega Epigenomic Controllers. These controllers are designed to selectively modulate genomic activity, enabling precise tuning of the human genome to treat various medical conditions. Founded in 2016 and rebranded from VL42, Inc. in 2017, Omega Therapeutics is dedicated to transforming human medicine by harnessing the innate potential of the genome for therapeutic benefits.

TScan Therapeutics

Series C in 2021
TScan Therapeutics is a biopharmaceutical company dedicated to discovering and developing innovative T cell receptor (TCR) engineered therapies to combat various cancers. Based in Waltham, Massachusetts, the company focuses on TCR-T therapies for both liquid cancers and solid tumors. Its lead candidates, TSC-100 and TSC-101, are designed to address hematologic malignancies, specifically targeting residual leukemia and preventing relapse after hematopoietic stem cell transplantation. In addition, TScan is advancing a multiplexed TCR-T therapy program aimed at treating a range of solid tumors. The company's proprietary platform identifies clinically relevant T cell antigens and minimizes off-target effects, enhancing the precision of its therapies. Founded in 2018, TScan Therapeutics is committed to improving outcomes for patients with serious diseases.

Immunocore

Series C in 2021
Immunocore Limited is a biotechnology company based in Abingdon, United Kingdom, with a focus on discovering and developing novel therapeutics for cancer, viral diseases, and autoimmune conditions. The company specializes in T cell receptor (TCR) technology, which allows it to create innovative bispecific immunotherapies. Its lead product candidate, IMCgp100, is currently undergoing clinical trials for the treatment of metastatic melanoma. Immunocore's proprietary platform enables efficient manufacturing of TCR-based drugs, addressing significant unmet medical needs. Founded in 1999 and previously known as Avidex Limited, Immunocore has expanded its operations with an additional office in Conshohocken.

Neon

Series C in 2020
Neon is a Brazilian fintech company founded in 2016, offering a digital banking platform and bill payment services. With over 15 million customers and 1,600 employees, Neon provides a range of products including debit and credit cards without annual fees, personal loans, investments in CDB and CDI, cashback on debit transactions, and various payment methods. Notably, Neon For Life, an AI-driven platform, enables consumers to pay bills like rent and utilities on flexible terms, without traditional credit pitfalls. The company aims to provide accessible, abusive-fee-free financial services to Brazilian workers and micro-entrepreneurs, with a focus on simplicity and convenience.

SOURCE

Series C in 2020
SOURCE, founded in 2014 and based in Scottsdale, Arizona, specializes in developing and manufacturing solar-powered devices aimed at extracting drinkable water from the atmosphere. Their innovative hydro panels employ advanced materials science to harvest water even in arid conditions, producing pure, mineralized water that is accessible via a tap. This technology caters to a wide range of applications, including industrial, commercial, residential, and community use, ensuring clean water availability virtually anywhere.

PsiQuantum

Series C in 2020
PsiQuantum is focused on developing the first utility-scale quantum computer to address significant global challenges. The company utilizes photonic qubits, which offer substantial advantages for creating a fault-tolerant, general-purpose quantum computer. By leveraging advanced semiconductor manufacturing capabilities, PsiQuantum aims to deliver quantum technology that can foster advancements across various sectors, including climate, healthcare, finance, energy, agriculture, transportation, and communications. This innovative approach positions PsiQuantum to contribute meaningfully to solving real-world problems through enhanced computational capabilities.

Kymera Therapeutics

Series C in 2020
Kymera Therapeutics is a biopharmaceutical company based in Watertown, Massachusetts, that specializes in the discovery and development of novel small molecule therapeutics aimed at selectively degrading disease-causing proteins. The company utilizes a proprietary platform for targeted protein degradation, leveraging the body’s natural protein recycling system. Kymera is developing several programs, including the IRAK4 program for immunology-inflammation diseases such as hidradenitis suppurativa and rheumatoid arthritis, the IRAKIMiD program to address MYD88-mutated diffuse large B cell lymphoma, and the STAT3 program targeting hematologic malignancies, solid tumors, and autoimmune diseases. Founded in 2015, Kymera Therapeutics is pioneering new approaches to treat diseases that have previously been considered untreatable, focusing on previously inaccessible therapeutic targets.

SambaNova Systems

Series C in 2020
SambaNova Systems, based in Palo Alto, California, develops a technology platform that integrates hardware and software solutions for artificial intelligence and machine learning applications. Founded in 2017, the company focuses on creating systems optimized for data processing, model training, and analytics, enabling high-performance execution of machine learning tasks. SambaNova's technology is designed to be flexible and scalable, catering to various sectors such as healthcare, finance, and autonomous vehicles. By enhancing the efficiency of AI-powered algorithms, SambaNova aims to support organizations in leveraging advanced data analytics effectively.

Arcutis Biotherapeutics

Series C in 2019
Arcutis Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Westlake Village, California, specializing in the development and commercialization of treatments for immune-mediated dermatological diseases. Founded in 2016, Arcutis is focused on addressing unmet medical needs in dermatology by leveraging advances in immunology and inflammation. Its lead product candidate, a topical cream formulation of roflumilast, is undergoing Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. Additionally, the company is developing other innovative therapies, including a topical foam formulation for seborrheic dermatitis and scalp psoriasis, a selective small molecule inhibitor for hand eczema, and a specialized formulation designed for alopecia areata. Arcutis aims to provide differentiated therapies that effectively tackle persistent treatment challenges in serious skin conditions.

Scalable Capital

Series C in 2019
Scalable Capital is a European fintech company aiming to democratize financial investments by combining people and technology-based investing. It operates a digital wealth management platform that uses proprietary risk management technology to automatically allocate portfolios based on individual risk tolerance. The platform offers low-cost portfolio management and on-demand financial advice, enabling users to invest in capital markets with smoother performance and better risk-adjusted returns. Scalable Capital serves both private investors (B2C) and has partnerships with prominent business clients (B2B). The company is backed by notable investors including BlackRock, Tencent, HV Capital, and Tengelmann Ventures.

Acorns

Series C in 2018
Acorns is a financial technology company founded in 2012 and based in Irvine, California. The company offers a mobile application that enables individuals to automate micro-investments by rounding up their everyday purchases and investing the spare change into a diversified portfolio of exchange-traded funds. Acorns employs a proprietary financial engine to facilitate these micro-investments, allowing users to invest small amounts of money effortlessly. In addition to its investment services, Acorns provides debit card, personal checking, investment, and retirement account options, making it easier for users to manage their finances and grow their savings over time.

Illumio

Series C in 2015
Illumio, Inc. is a cybersecurity company based in Sunnyvale, California, founded in 2012. It specializes in cloud-based security solutions designed to protect organizations from cyber threats and enhance operational resilience. The company's core offering is the Adaptive Security Platform, which includes tools for data center and cloud traffic security. Key components of this platform are the Illumination application traffic mapping tool, the Enforcement application nano-segmentation solution, and SecureConnect for data protection. Illumio's approach centers on Zero Trust principles, helping organizations visualize traffic flows and implement segmentation policies that limit lateral movement within multi-cloud and hybrid infrastructures. This capability is essential for safeguarding critical resources and preventing the spread of cyber attacks. Illumio serves a diverse clientele, including notable companies such as Plantronics, Yahoo, Creative Artists Agency, and NTT Innovation Institute, Inc.

Dropbox

Series C in 2014
Dropbox, established in 2007, is a leading provider of secure file sharing, collaboration, and storage solutions. It pioneered cloud storage and cross-platform file syncing, initially targeting individuals and small to medium-sized businesses (SMBs). Over time, Dropbox has expanded its product mix, diversifying beyond its core cloud-storage offerings to cater to a broader range of users and use cases. Its mission is to "unleash the world’s creative energy by designing a more enlightened way of working."

Personal Capital

Series C in 2013
Personal Capital Corporation is a digital wealth management company that offers financial advisory services and innovative software solutions to help individuals manage their finances effectively. Founded in 2009 and headquartered in Redwood Shores, California, the company provides tools that allow users to monitor income, spending, and investment performance in one place. Its services include wealth management, personalized financial planning, risk assessments, and investment checkup tools. With a user base exceeding 2.5 million customers, Personal Capital combines advanced technology with expert guidance from registered investment advisors to deliver customized financial strategies aligned with clients' goals. Originally known as SafeCorp Financial Corp., the company rebranded to Personal Capital in June 2010, reflecting its commitment to enhancing personal financial management through technology.

Aperio Technologies

Series C in 2008
Aperio Technologies is a leading provider of digital pathology solutions, serving hospitals, reference labs, and pharmaceutical and research institutions globally. The company's comprehensive product portfolio enhances patient care by improving quality assurance, streamlining workflows, and facilitating access to targeted therapies. Aperio offers a range of products, including ScanScope scanners, Spectrum image management software, the SecondSlide slide sharing service, and various image analysis tools. These products are FDA cleared for specific clinical applications and are also intended for research and educational purposes. Through its innovative solutions, Aperio aims to improve the skills of pathologists and contribute to advancements in the field of pathology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.